tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRAX Stock Latest News

Praxis Precision participates in a conference call with H.C. Wainwright
The FlyPraxis Precision participates in a conference call with H.C. Wainwright
21h ago
PRAX
Praxis Precision announces inducement grants under Nasdaq lsiting rule
PremiumThe Fly
Praxis Precision announces inducement grants under Nasdaq lsiting rule
2d ago
PRAX
Praxis Precision Medicines Reports Q3 2025 Financial Results
PremiumCompany Announcements
Praxis Precision Medicines Reports Q3 2025 Financial Results
2d ago
PRAX
Positive Phase 3 Trial Results and Strong Financial Position Drive Buy Rating for Praxis Precision Medicines
PremiumRatings
Positive Phase 3 Trial Results and Strong Financial Position Drive Buy Rating for Praxis Precision Medicines
2d ago
PRAX
Praxis Precision Medicines: Buy Rating Affirmed on Promising Phase III Results and Market Potential
PremiumRatings
Praxis Precision Medicines: Buy Rating Affirmed on Promising Phase III Results and Market Potential
3d ago
PRAX
Praxis Precision reports Q3 EPS ($3.36), consensus ($3.49)
PremiumThe FlyPraxis Precision reports Q3 EPS ($3.36), consensus ($3.49)
3d ago
PRAX
Praxis Precision sees cash runway into 2028
Premium
The Fly
Praxis Precision sees cash runway into 2028
3d ago
PRAX
Positive Outlook for Praxis Precision Medicines: Buy Rating Affirmed Amid Promising FDA Feedback and Strong Efficacy Data
Premium
Ratings
Positive Outlook for Praxis Precision Medicines: Buy Rating Affirmed Amid Promising FDA Feedback and Strong Efficacy Data
4d ago
PRAX
Buy Rating for Praxis Precision Medicines Driven by Promising FDA Progress and Positive Study Outcomes
PremiumRatings
Buy Rating for Praxis Precision Medicines Driven by Promising FDA Progress and Positive Study Outcomes
4d ago
PRAX
Praxis Precision Medicines: Buy Rating Backed by Accelerated FDA Approval Path and Promising Relutrigine Data
PremiumRatings
Praxis Precision Medicines: Buy Rating Backed by Accelerated FDA Approval Path and Promising Relutrigine Data
4d ago
PRAX
Praxis Precision reaches alignment with FDA for relutrigine program
PremiumThe Fly
Praxis Precision reaches alignment with FDA for relutrigine program
4d ago
PRAX
Praxis Precision Medicines Advances Elsunersen Trial for Pediatric Epileptic Encephalopathy
PremiumCompany Announcements
Praxis Precision Medicines Advances Elsunersen Trial for Pediatric Epileptic Encephalopathy
12d ago
PRAX
Praxis Precision Medicines Advances Phase 3 Trial for DEE Treatment
PremiumCompany AnnouncementsPraxis Precision Medicines Advances Phase 3 Trial for DEE Treatment
12d ago
PRAX
Praxis Precision Medicines Advances Phase 3 Study for Essential Tremor Treatment
Premium
Company Announcements
Praxis Precision Medicines Advances Phase 3 Study for Essential Tremor Treatment
12d ago
PRAX
Praxis Precision Medicines’ PRAX-222 Trial: A Potential Game-Changer for Pediatric Epilepsy
Premium
Company Announcements
Praxis Precision Medicines’ PRAX-222 Trial: A Potential Game-Changer for Pediatric Epilepsy
12d ago
PRAX
Praxis Precision Medicines’ PRAX-628 Study: A Potential Game-Changer for Focal Seizures
PremiumCompany Announcements
Praxis Precision Medicines’ PRAX-628 Study: A Potential Game-Changer for Focal Seizures
12d ago
PRAX
Praxis Precision Medicines Advances Seizure Treatment with PRAX-628 Trial
PremiumCompany Announcements
Praxis Precision Medicines Advances Seizure Treatment with PRAX-628 Trial
12d ago
PRAX
Praxis Precision Medicines: Evaluating PRAX-628’s Bioavailability in New Clinical Trial
PremiumCompany Announcements
Praxis Precision Medicines: Evaluating PRAX-628’s Bioavailability in New Clinical Trial
12d ago
PRAX
Praxis Precision Medicines’ PRAX-562 Trial: A Potential Game-Changer for Epileptic Encephalopathies
PremiumCompany Announcements
Praxis Precision Medicines’ PRAX-562 Trial: A Potential Game-Changer for Epileptic Encephalopathies
12d ago
PRAX
3 Stocks with a Flawless 10 Smart Score and Strong Buy Consensus
PremiumMarket News3 Stocks with a Flawless 10 Smart Score and Strong Buy Consensus
16d ago
IRON
PRAX
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
17d ago
KDK
LGO
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
18d ago
BNC
KDK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >